Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial.

Patrick AltmannMarkus PonleitnerTobias MonscheinNik KrajncGudrun ZulehnerTobias ZrzavyFritz LeutmezerPaulus Stefan RommerBarbara KornekThomas BergerGabriel Bsteh

Published in: Digital health (2022)

NCT04555863.

Keyphrases

patient reported outcomes
multiple sclerosis
phase iii
study protocol
phase ii
clinical trial
white matter
randomized controlled trial
double blind
placebo controlled